These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 33802737)

  • 21. IL-17A haplotype confers susceptibility to systemic lupus erythematosus but not to rheumatoid arthritis in Mexican patients.
    Montúfar-Robles I; Barbosa-Cobos RE; Alemán-Ávila I; Ramírez-Bello J
    Int J Rheum Dis; 2019 Mar; 22(3):473-479. PubMed ID: 30398030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
    Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
    J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations of IL-17 and NF-κB gene polymorphisms with susceptibility and prognosis in acute respiratory distress syndrome in a chinese population.
    Xie M; Cheng B; Ding Y; Wang C; Chen J
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30655311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
    Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
    Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
    Nomura M; Shigematsu H; Li L; Suzuki M; Takahashi T; Estess P; Siegelman M; Feng Z; Kato H; Marchetti A; Shay JW; Spitz MR; Wistuba II; Minna JD; Gazdar AF
    PLoS Med; 2007 Apr; 4(4):e125. PubMed ID: 17455987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
    Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
    Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
    Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of EGFR 1 Gene Alteration and their Association with Lung Adenocarcinoma Patients.
    Ali Beg MM; Fahdil SR; Yadav P; Shukla KK; Mohan A; Saxena A
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):825-830. PubMed ID: 30912007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-17A and -17F genes polymorphisms in lung cancer.
    Kaabachi W; ben Amor A; Kaabachi S; Rafrafi A; Tizaoui K; Hamzaoui K
    Cytokine; 2014 Mar; 66(1):23-9. PubMed ID: 24548421
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Li JP; Hsieh MJ; Chou YE; Chao YH; Tsao TC; Yang SF
    Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32344833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
    Yuan P; Huang S; Bao FC; Cao JL; Sheng HX; Shi L; Lv W; Hu J
    Eur J Cancer; 2019 Oct; 120():10-19. PubMed ID: 31446212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rs2275913 polymorphism of the interleukin-17A gene is associated with the risk of ovarian endometriosis.
    Xie Z; Ding X; Wang Y; Zhang M
    J Obstet Gynaecol; 2023 Dec; 43(1):2199852. PubMed ID: 37066601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation.
    Liu TC; Hsieh MJ; Liu MC; Chiang WL; Tsao TC; Yang SF
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of genetic variation and mRNA expression of interleukin-17A gene on susceptibility to asthma.
    Han X; Jin F; Liu H; Chen Y; Dong S; Cui B
    Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):195-199. PubMed ID: 38015521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC.
    Yang S; Mao S; Li X; Zhao C; Liu Q; Yu X; Wang Y; Liu Y; Pan Y; Wang C; Gao G; Li W; Xiong A; Chen B; Sun H; He Y; Wu F; Chen X; Su C; Ren S; Zhou C
    Lung Cancer; 2020 Jan; 139():133-139. PubMed ID: 31786475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogene HSPH1 modulated by the rs2280059 genetic variant diminishes EGFR-TKIs efficiency in advanced lung adenocarcinoma.
    Li Y; Zhang N; Zhang L; Song Y; Liu J; Yu J; Yang M
    Carcinogenesis; 2020 Sep; 41(9):1195-1202. PubMed ID: 32815538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 17A and interleukin 17F polymorphisms are associated with oral squamous cell carcinoma susceptibility in a Chinese population.
    Li N; Zhang C; Chen Z; Bai L; Nie M; Zhou B; Xu H
    J Oral Maxillofac Surg; 2015 Feb; 73(2):267-73. PubMed ID: 25579009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SNPs in the transforming growth factor-β pathway as predictors of outcome in advanced lung adenocarcinoma with EGFR mutations treated with gefitinib.
    Zhang L; Li QX; Wu HL; Lu X; Yang M; Yu SY; Yuan XL
    Ann Oncol; 2014 Aug; 25(8):1584-90. PubMed ID: 24928833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population.
    Qinghai Z; Yanying W; Yunfang C; Xukui Z; Xiaoqiao Z
    Gene; 2014 Mar; 537(2):328-32. PubMed ID: 24315816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of "Lung Cancer Management in Indian context".
    Nakra T; Mehta A; Bal A; Nambirajan A; Mishra D; Midha D; Gupta N; Arora N; Gupta P; Gupta P; Singh V; Jain D
    Curr Probl Cancer; 2020 Jun; 44(3):100561. PubMed ID: 32169258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.